Lancet Global Health

Papers
(The H4-Index of Lancet Global Health is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Global health research funding applications: brain drain under another name?771
Bringing home manufacturing of medical products747
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou312
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply312
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m271
Influenza vaccination in failing hearts270
The future of the International Health Regulations260
The health status of Indonesia's provinces: the double burden of diseases and inequality gap259
Implementation of dual maternal HIV-Syphilis testing: The devil is in the details224
C-reactive protein: another addition to our armamentarium against tuberculosis?222
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)206
Preventing pellagra during isoniazid preventive treatment201
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor194
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr191
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6177
Correction to Lancet Glob Health 2021; 9: e1679–87174
Correction to Lancet Glob Health 2021; 9: e908–09172
Challenges in operationalising clinical trials in India during the COVID-19 pandemic159
The cause of nodding syndrome remains unknown159
Outcomes of rheumatic fever in Uganda: a prospective cohort study150
Racism and health: the need for urgent action149
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis148
Indonesia's first nationwide health screening programme139
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study135
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys134
COVID-19 pandemic and health-care disruptions: count the most vulnerable130
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study126
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study126
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study126
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial125
Mpox vaccination strategies in DR Congo121
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial120
Global patterns and trends in Kaposi sarcoma incidence: a population-based study120
Resolving the CD4-testing crisis to help end AIDS-related deaths119
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis119
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study116
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study115
Is now the time for revisiting supplements for pregnant women?115
Challenges in interpreting SARS-CoV-2 serological results in African countries111
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study109
The drug drought in maternal health: an ongoing predicament106
Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis101
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019101
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis96
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial96
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all94
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply93
Next generation economics of universal HIV treatment93
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study92
Addressing the complex needs of people with severe mental health disorders in low-resource settings91
Mpox: evidence for strengthening and sustaining global surveillance91
Commitment and innovation on the road to people-centred PHC financing89
Achieving sensible targets for a diabetes care cascade in LMICs89
Pregnancy in people who have survived Ebola virus disease88
From child institutions to family reunification: challenges and opportunities in building family-centred care87
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–2085
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation84
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition83
Understanding deaths from diarrhoea in children younger than 5 years83
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research81
Cervical cancer elimination: actions needed in the COVID-19 era80
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study80
Resetting the agenda for antibiotic resistance through a health systems perspective79
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns79
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review79
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control79
Cholera rapid diagnostic tests recycled for PCR confirmation78
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security77
Using theory to understand how interventions work and inform future implementation77
Lessons for future implementation of the E-MOTIVE bundle76
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned75
Payment in arrears: a global health inequity that must be corrected75
Improving access to liposomal amphotericin B worldwide74
Impact of excluded studies on medical male circumcision and HIV risk compensation73
0.080640077590942